Dokumentuaren aipamena

APA (7th ed.) Zitazioa
Rajtar-Salwa, R., Bobrowska, B., Socha, S., Dziewierz, A., Siudak, Z., Batko, J., . . . Krawczyk-Ożóg, A. (2024). Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk. MDPI AG.
Chicago Style (17th ed.) Zitazioa
Rajtar-Salwa, Renata, Beata Bobrowska, Sylwia Socha, Artur Dziewierz, Zbigniew Siudak, Jakub Batko, Stanisław Bartuś, eta Agata Krawczyk-Ożóg. Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk. MDPI AG, 2024.
MLA (9th ed.) Zitazioa
Rajtar-Salwa, Renata, et al. Efficacy of Alirocumab, Evolocumab, and Inclisiran in Patients with Hypercholesterolemia at Increased Cardiovascular Risk. MDPI AG, 2024.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.